Cardiovascular Disease Medications After Renal Transplantation: Results From the Patient Outcomes in Renal Transplantation Study

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Transplantation

• Publication date

  2011-03-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/TP.0b013e31820437bdPMID 21301401
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Predicting Coronary Heart Disease after Kidney Transplantation: Patient Outcomes in Renal Transplantation (PORT) Study

  2010influential reference
• Standards of Medical Care in Diabetes—2009

  2009cited by this paper
• Antihypertensives for Kidney Transplant Recipients: Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2009cited by this paper
• Use of Cardioprotective Medications in Kidney Transplant Recipients

  2009cited by this paper
• 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2008cited by this paper
• Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis.

  2008cited by this paper
• Determinants and patterns of renin–angiotensin system inhibitors’ prescription in the first year following kidney transplantation

  2008cited by this paper
• 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

  2008cited by this paper
• 2202 Kidney Transplant Recipients with 10 Years of Graft Function: What Happens Next?

  2008cited by this paper
• Focused Update of the ACC / AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction

  2007cited by this paper
• Mellitus: A Scientific Statement From the American Heart Association and the Primary Prevention of Cardiovascular Diseases in People With Diabetes

  2007cited by this paper
• Comparisons of guideline-recommended therapies in patients with documented coronary artery disease having percutaneous coronary intervention versus coronary artery bypass grafting versus medical therapy only (from the REACH International Registry).

  2007influential reference
• Cardiovascular Complications After Renal Transplantation and Their Prevention

  2006cited by this paper
• Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus

  2006cited by this paper
• A randomized trial comparing losartan with amlodipine as initial therapy for hypertension in the early post-transplant period.

  2006cited by this paper
• Risk Factors for Cardiovascular Events After Successful Renal Transplantation

  2005cited by this paper
• K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.

  2005cited by this paper
• Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.

  2004cited by this paper
• Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

  2004cited by this paper
• K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease.

  2004cited by this paper
• Fluvastatin Prevents Cardiac Death and Myocardial Infarction in Renal Transplant Recipients: Post‐Hoc Subgroup Analyses of the ALERT Study

  2004cited by this paper
• Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial.

  2003cited by this paper
• Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

  2002cited by this paper
• European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.5.3. Cardiovascular risks. Hyperlipidaemia.

  2002cited by this paper
• Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomised trials

  2001cited by this paper

• Heart Failure in Kidney Transplant Recipients: Narrative Review of Risk Factors, Therapy, and Current Gaps in Management.

  2026cites this paper
• Impact of Renin-Angiotensin System Blockade on Mortality and Allograft Loss among Renal Transplant Recipients: A Systematic Review and Meta-Analysis

  2024influential citation
• Clinical Outcomes of Renal Transplant Recipients Undergoing Percutaneous Coronary Intervention.

  2024cites this paper
• Analysis of the correlation between hypercholesterolemia and increased Cardiovascular Morbidity and Mortality among Adult Kidney Transplant Recipients.

  2024cites this paper
• Long-term cardiovascular events, graft failure, and mortality in kidney transplant recipients.

  2023cites this paper
• Delivery of costimulatory blockade to lymph nodes promotes transplant acceptance in mice

  2022cites this paper
• Racial Differences in Medication Utilization for Secondary Prevention of Cardiovascular Disease in Kidney Transplant Recipients: A Post Hoc Analysis of the FAVORIT Trial Cohort

  2022cites this paper
• Hypertension after kidney transplantation

  2022cites this paper
• Remnant cholesterol is prospectively associated with CVD events and all-cause mortality in kidney transplant recipients: the FAVORIT study.

  2021cites this paper
• Remnant cholesterol is prospectively associated with cardiovascular disease events and all-cause mortality in kidney transplant recipients: the FAVORIT study

  2021cites this paper
• Microalbuminuria After Kidney Transplantation Predicts Cardiovascular Morbidity

  2021cites this paper
• ACTH treatment promotes murine cardiac allograft acceptance

  2021cites this paper
• The renin-angiotensin-aldosterone system blockade and arterial stiffness in renal transplant recipients – a cross-sectional prospective observational clinical study

  2020influential citation
• The Argument for Abolishing Cardiac Screening of Asymptomatic Kidney Transplant Candidates.

  2020cites this paper
• The Impact of Cardiovascular Disease Risk Factors on Late Graft Outcome Disparities in Adult African American Kidney Transplant Recipients

  2020cites this paper
• Caring for the patient with a failing allograft: challenges and opportunities.

  2019cites this paper
• Cardiovascular Disease in Renal Transplantation

  2019cites this paper
• One-year Allograft and Patient Survival in Renal Transplant Recipients Receiving Antiplatelet Therapy at the Time of Transplantation

  2018cites this paper
• Renal transplantation increases angiotensin II receptor-mediated vascular contractility associated with changes of epigenetic mechanisms.

  2018cites this paper
• Renal association clinical practice guideline in post-operative care in the kidney transplant recipient

  2017cites this paper
• Incidence, Management, and Risk Factors for Lower Gastrointestinal Bleeding in Renal Transplant Recipients.

  2017cites this paper
• The effect of aspirin on kidney allograft outcomes; a short review to current studies

  2017cites this paper
• Statin use and hip fractures in U.S. kidney transplant recipients

  2017cites this paper
• Active targeted delivery of immune therapeutics to lymph nodes

  2017cites this paper
• Post-transplantation diabetes-state of the art.

  2016cites this paper
• Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant Recipients

  2016cites this paper
• Left ventricle ejection fraction may predict mortality in renal transplant patients

  2016cites this paper
• Renal transplantation in adults

  2016cites this paper
• Medical management of chronic kidney disease in the renal transplant recipient

  2015cites this paper
• Investigation of association between donors' and recipients' NADPH oxidase p22(phox) C242T polymorphism and acute rejection, delayed graft function and blood pressure in renal allograft recipients.

  2015cites this paper
• Implementation of guidelines for metabolic syndrome control in kidney transplant recipients: results at a single center

  2015cites this paper
• Cardiovascular risk factors following renal transplant.

  2015cites this paper
• Prediction and diagnosis of post transplant diabetes.

  2015cites this paper
• Cardiovascular morbidity and mortality after kidney transplantation

  2015cites this paper
• Significant Racial Differences in the Key Factors Associated with Early Graft Loss in Kidney Transplant Recipients

  2014cites this paper
• Improving long-term outcomes of kidney transplantation: The pressure is on.

  2014cites this paper
• BP targets in renal transplant recipients: too high or too low?

  2014cites this paper
• Cardiovascular Disease and Preventive Healthcare after Organ Transplantation

  2014cites this paper
• The Prevention and Treatment of Coronary Artery Disease in Kidney Transplant Recipients

  2014cites this paper
• Treatment-resistant hypertension in the transplant recipient.

  2014cites this paper
• B cells and kidney transplantation: beyond antibodies.

  2014cites this paper
• Pre‐existing diabetes significantly increases the risk of graft failure and mortality following renal transplantation

  2013cites this paper
• Are Thiazide Diuretics Safe and Effective Antihypertensive Therapy in Kidney Transplant Recipients?

  2013cites this paper
• The Impact of Cardiovascular Disease and Risk Factor Treatment on Ethnic Disparities in Kidney Transplant

  2013cites this paper
• Update on the long-term complications of renal transplantation.

  2013cites this paper
• Has patient survival following renal transplantation improved in the era of modern immunosuppression?

  2013cites this paper
• New‐Onset Diabetes After Kidney Transplantation—Changes and Challenges

  2012cites this paper
• Prevalence of arterial hypertension and the number and classes of antihypertensive drugs prescribed for patients late after kidney transplantation.

  2012cites this paper
• Kidney Function and Risk of Cardiovascular Disease and Mortality in Kidney Transplant Recipients: The FAVORIT Trial

  2012cites this paper
• Current world literature.

  2012cites this paper
• Clinical Practice Guidelines on Wait-Listing for Kidney Transplantation: Consistent and Equitable?

  2012cites this paper
• Prevention of cardiovascular disease after renal transplantation

  2012cites this paper
• Inadequacy of cardiovascular risk factor management in chronic kidney transplantation – evidence from the FAVORIT study

  2012cites this paper
• Renin-angiotensin system blockade and kidney transplantation: a longitudinal cohort study.

  2012cites this paper
• Prevention of cardiovascular disease in adult recipients of kidney transplants.

  2011cites this paper
• Medications to reduce cardiovascular risk after kidney transplantation.

  2011cites this paper
• Hypertension in the kidney transplant recipient.

  2010cites this paper
• Update on the Long-term Complications of Renal Transplantation Cardiovascular Disease Predicting Risk Long-term Renal Transplant Complications

  year unknowncites this paper